Transfusion Associated Dyspnea Profiling

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

151 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-01

Study Completion Date

2022-12-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Transfusion reactions are defined as harms occurring during or after blood transfusion, with new heart/lung stress (eg. troubled breathing) regarded as cardiorespiratory transfusion reactions (CRTRs). CRTRs are among the most important, as the leading cause of transfusion-related harm and death. Though there are distinct classifications for these events, real life cases often don't fall neatly into a given category, with outliers regarded as "transfusion associated dyspnea (TAD)". It is unknown what TAD is -- whether it has a unique root cause, is a milder version of other known CRTRs, or is a blend of events. The purpose of this study is to better understand TAD and CRTRs by profiling them through a detailed medical history and more intensive laboratory assessment. This review of CRTRs may improve the quality/validity of final conclusions reported in the health record and to hemovigilance bodies, and uncover the nature of TAD and/or minimize CRTRs defaulting to the TAD category. Our enhanced understanding will advance diagnostic, treatment, and prevention efforts.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Thoracic Fluid Content and Acute Lung Injury

NCT01922557

Acute Lung Injury

COMPLETED

Therapeutic Thoracentesis for Patients With Congestive Heart Failure and Large Pleural Effusion

NCT00629538

Congestive Heart Failure Transudative Pleural Effusion

COMPLETED NA

Blood Transfusions in Coronary Artery Bypass Surgery

NCT02953951

Excessive Amount of Blood / Fluid Transfusion

COMPLETED

Study of the Clinical Scoring System and Cytokines for Prediction of Inflammatory Response in Major Surgery

NCT01353157

Heart; Dysfunction Postoperative, Cardiac Surgery Cytokine Release Syndrome

COMPLETED

Stress-induced Vascular Dysfunction: Evaluation of Endothelial Function in a Cohort of Patients With Takotsubo Syndrome

NCT01249599

Takotsubo Syndrome

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

"Transfusion-Associated Dyspnea: Prospective Observation and Laboratory Assessment" (TADPOL) aims to improve the diagnosis and characterization of cardiorespiratory transfusion reaction (CRTR) patients ("cases"), as compared with high risk febrile transfusion reaction (HRFTR) patients ("controls"), by applying a standardized and intensive clinicolaboratory profiling tool.

CRTR, in contrast with HRFTR, are more difficult to diagnose and manage. Patients are often sick with (or prone to) pathologies that resemble reactions (eg. congestive heart failure \[CHF\] vs transfusion associated circulatory overload \[TACO\]), and/or experience more than one transfusion-associated disturbance at a time.

CRTRs are also the most disruptive, distressing, and disposition-escalating events for patients at an individual level, and are disproportionately accountable for transfusion associated deaths at the collective level in national hemovigilance systems. The cardinal CRTRs range from TACO (most commonly) to allergic bronchospasm to transfusion related acute lung injury (TRALI).

Inaccurate classification may undercount certain phenomena (when criteria fail to be met by confounding conditions), and/or overcount others (when including all possibilities-of-relevance in hemovigilance).

These uncertainties beget gaps (or excesses) in patient care and in donor/product-associated decision-making.

HYPOTHESES: The TADPOL CRF and laboratory profiling effort will improve the yields of confident (more certain), accurate (better-grounded), and thorough (multi-event-sensitive) diagnoses in CRTR patients.

Most cases of TAD are likely to be re-classified as milder versions (or overlaps) of possible CRTR states (± the underlying condition), while the remainder may exhibit a signature resembling FNHTR (FTR controls).

Precise case-mapping should yield useful personalized information, while aggregated findings from each disturbance pathway - as they are distributed in each conventional reaction category - can validate the utility of markers being explored in reaction investigation algorithms.

The TADPOL bioarchive and anonymized dataset will also be assets for explorations of novel indicators and patterns.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Transfusion Reaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cases: CRTR (cardiorespiratory transfusion reaction)

Respiratory/cardiovascular disturbances after transfusion (\>/=2 of respiratory distress, pulmonary edema, cardiovascular system changes, fluid shifts, cardiac strain indicators), with or without accompanying (or pre-existing) fever

TADPOL battery (deep clinicolaboratory profile)

Intervention Type DIAGNOSTIC_TEST

profile dimensions:

* hemolytic
* allergic
* cardiorenal
* inflammatory
* leukoagglutinating
* exploratory bioarchive

Controls: HRFTR (high risk febrile transfusion reactions)

Post-transfusion fevers requiring laboratory investigation (Tmax\>/=39C, or lesser deflections if accompanied by chills/rigors), without respiratory features (hypoxia or dyspnea)

TADPOL battery (deep clinicolaboratory profile)

Intervention Type DIAGNOSTIC_TEST

profile dimensions:

* hemolytic
* allergic
* cardiorenal
* inflammatory
* leukoagglutinating
* exploratory bioarchive

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TADPOL battery (deep clinicolaboratory profile)

profile dimensions:

* hemolytic
* allergic
* cardiorenal
* inflammatory
* leukoagglutinating
* exploratory bioarchive

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Transfusion of blood products (components or derivatives) with an available pre-transfusion group \& screen specimen
* Referred to the blood transfusion laboratory for review of a suspected acute transfusion reaction (occurring within 24 hours of completing transfusion), and either exhibiting a cardiorespiratory disturbance (CRTR: cases) or a high-risk febrile disturbance (HRFTR: controls)

Exclusion Criteria

* Pregnant females
* Massive hemorrhage entailing \>20 implicated products in the 24h period before the acute transfusion reaction's onset
* Previous enrolment in the same designation (ie- an individual with RTR will not re-enroll if having another RTR, but may re-enrol if having FTR)
* Expected to discharge home or die sooner than specimen acquisition
* Withdrawal of consent at any time

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No